• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AIBioTech

edit

AIBioTech provides drug discovery and diagnostic development organizations a broad range of world-class laboratory services to bring new products to market.

Located in a 32,000 square foot laboratory in Richmond, Virginia, AIBioTech is one of the world’s most comprehensive Contract Research Organizations in operation. AIBioTech provides reliable expertise and cutting-edge technologies which are not available from other companies.

An expert core laboratory, we provide consultation on experimental design and offer comprehensive services under GLP and non-GLP compliance. These services are offered individually or can be integrated to support product development from discovery-to-market with full Regulatory Support under FDA GLP Guidelines 21 CFR 58.

AIBioTech provides the following capabilities to clients:

Molecular biology Protein expression & analysis and peptide synthesis & purification Bio-analytical services (CLIA certified) Assay development and validation Microbiology, virology & biosafety testing (BSL3 facilities) Program expertise

Recent Milestones

edit

• 
  AIBioTech — AIBioTech expands forensic capabilities with Mitotyping Technologies (7/16/12)
  Posted 7/19/12 at 8:52pm via marketwatch.com
• 
  AIBioTech — AI BioTech wins $ 4.3 Million Next Generation Sequence and Bioinformatic Analysis contract (7/9/12)
  Posted 7/19/12 at 8:51pm via marketwatch.com

Videos

Screenshots

edit

Sources

AI BioTech Announces $ 4.3 Million Contract Award (marketwatch.com) [edit]
AIBioTech Purchases Mitotyping Technologies (marketwatch.com) [edit]